Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 2
1952 2
1953 1
1954 2
1956 2
1958 2
1959 1
1964 2
1966 1
1970 1
1972 1
1974 1
1975 1
1976 2
1977 1
1979 3
1980 1
1983 1
1984 1
1986 1
1987 1
1988 2
1989 1
1990 1
1994 1
1997 1
1998 2
1999 1
2001 6
2002 1
2004 1
2005 1
2006 3
2007 3
2008 3
2009 4
2010 5
2011 7
2012 1
2013 1
2014 4
2015 3
2016 2
2017 6
2018 3
2019 2
2022 4
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer.
Hoyos V, Vasileiou S, Kuvalekar M, Watanabe A, Tzannou I, Velazquez Y, French-Kim M, Leung W, Lulla S, Robertson C, Foreman C, Wang T, Bulsara S, Lapteva N, Grilley B, Ellis M, Osborne CK, Coscio A, Nangia J, Heslop HE, Rooney CM, Vera JF, Lulla P, Rimawi M, Leen AM. Hoyos V, et al. Among authors: lapteva n. Ther Adv Med Oncol. 2022 Jul 15;14:17588359221107113. doi: 10.1177/17588359221107113. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35860837 Free PMC article.
Biology of oligotrophic bacteria.
Kuznetsov SI, Dubinina GA, Lapteva NA. Kuznetsov SI, et al. Among authors: lapteva na. Annu Rev Microbiol. 1979;33:377-87. doi: 10.1146/annurev.mi.33.100179.002113. Annu Rev Microbiol. 1979. PMID: 386927 Review. No abstract available.
CCL5 as an adjuvant for cancer immunotherapy.
Lapteva N, Huang XF. Lapteva N, et al. Expert Opin Biol Ther. 2010 May;10(5):725-33. doi: 10.1517/14712591003657128. Expert Opin Biol Ther. 2010. PMID: 20233026 Review.
Visuo-spatial imagery in dreams of congenitally and early blind: a systematic review.
Ilic K, Bertani R, Lapteva N, Drakatos P, Delogu A, Raheel K, Soteriou M, Mutti C, Steier J, Carmichael DW, Goadsby PJ, Ockelford A, Rosenzweig I. Ilic K, et al. Among authors: lapteva n. Front Integr Neurosci. 2023 Jun 30;17:1204129. doi: 10.3389/fnint.2023.1204129. eCollection 2023. Front Integr Neurosci. 2023. PMID: 37457556 Free PMC article. Review.
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
Steffin D, Ghatwai N, Montalbano A, Rathi P, Courtney AN, Arnett AB, Fleurence J, Sweidan R, Wang T, Zhang H, Masand P, Maris JM, Martinez D, Pogoriler J, Varadarajan N, Thakkar SG, Lyon D, Lapteva N, Mei Z, Patel K, Lopez-Terrada D, Ramos C, Lulla P, Armaghany T, Grilley BJ, Dotti G, Metelitsa LS, Heslop HE, Brenner MK, Sumazin P, Heczey A. Steffin D, et al. Among authors: lapteva n. Res Sq [Preprint]. 2024 Apr doi: 10.21203/ Res Sq. 2024. PMID: 38645165 Free PMC article. Preprint.
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.
Hegde M, Navai S, DeRenzo C, Joseph SK, Sanber K, Wu M, Gad AZ, Janeway KA, Campbell M, Mullikin D, Nawas Z, Robertson C, Mathew PR, Zhang H, Mehta B, Bhat RR, Major A, Shree A, Gerken C, Kalra M, Chakraborty R, Thakkar SG, Dakhova O, Salsman VS, Grilley B, Lapteva N, Gee A, Dotti G, Bao R, Salem AH, Wang T, Brenner MK, Heslop HE, Wels WS, Hicks MJ, Gottschalk S, Ahmed N. Hegde M, et al. Among authors: lapteva n. Nat Cancer. 2024 Apr 24. doi: 10.1038/s43018-024-00749-6. Online ahead of print. Nat Cancer. 2024. PMID: 38658775
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
Naik S, Vasileiou S, Tzannou I, Kuvalekar M, Watanabe A, Robertson C, Lapteva N, Tao W, Wu M, Grilley B, Carrum G, Kamble RT, Hill L, Krance RA, Martinez C, Tewari P, Omer B, Gottschalk S, Heslop HE, Brenner MK, Rooney CM, Vera JF, Leen AM, Lulla PD. Naik S, et al. Among authors: lapteva n. Blood. 2022 Apr 28;139(17):2706-2711. doi: 10.1182/blood.2021014648. Blood. 2022. PMID: 35134127 Free PMC article.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Steffin DHM, Muhsen IN, Hill LC, Ramos CA, Ahmed N, Hegde M, Wang T, Wu M, Gottschalk S, Whittle SB, Lulla PD, Mamonkin M, Omer B, Rouce RH, Heczey A, Metelitsa LS, Grilley BJ, Robertson C, Torrano V, Lapteva N, Gee AP, Rooney CM, Brenner MK, Heslop HE. Steffin DHM, et al. Among authors: lapteva n. Blood. 2022 Jul 7;140(1):16-24. doi: 10.1182/blood.2022015728. Blood. 2022. PMID: 35325065 Free PMC article.
103 results